The Drug Development Letter
Vinay PrasadDr Prasad currently works at the US FDA. The writings on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
| Platform |  | Pricing | Only free issues | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 104 | Founded | 3 years ago | Last Issue | 10 months ago |
| Active | |||||
Read this Newsletter
drugdevletter.comLatest Issues
Can I confidently say to patients that a 3-year structured exercise program may save their lives? The CHALLENGE trial (part 2)
A brief recap: the CHALLENGE trial enrolled patients treated for colon cancer and adjuvant chemotherapy and randomized them to receive either health-educational materials only (control patients), or similar materials plus a 3-year supervise...
The online BREAKING-ICE App© out in The Lancet Oncology !
The online BREAKING-ICE App© has been published recently in The Lancet Oncology, co-authored with Vinay Prasad and Alyson Haslam.
Informative censoring will no longer be a dry concept, you'll be able to visualize it live!
This freely a...
Does a 3-year structured exercise program save lives? Part 1
I want to start by congratulating the authors, the investigators, and the patients for participating and conducting the CHALLENGE trial, presented during the ASCO 2025 meeting, one of the biggest oncology conference worldwide.
The CHA...
"LUNAR: Full Moon or Eclipse? An exploration into tumor treating fields in lung cancer"
The LUNAR trial
Our new paper, co-authored with Vinay Prasad, is out in the Journal of Cancer Policy. It is an analysis of the LUNAR trial and raises broader questions about Tumor Treating Fields.
Tumor Treating Fields (TTFs) are a me...
How to appraise the control arm in oncology trials, in 10 minutes!
On 26 March 2025, I had the pleasure and honor of being kindly invited by Professor Silke Gillessen, Head of the Oncology Institute of Southern Switzerland (IOSI) at the Ente Ospedaliero Cantonale (EOC), to deliver a lecture entitled: “Step...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for The Drug Development Letter.
| Subscribers | Monthly Web Visits | Accepts Sponsors | |||
|---|---|---|---|---|---|
| Estimated Cost per Ad | |||||
Explore More
Authors
The writers behind this newsletter.
Hematology Oncology Medicine Health Policy Epidemiology Professor
Social
Frequently Asked Questions
How can I access the email archive for The Drug Development Letter?
You can find recent issues that have been published by The Drug Development Letter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Drug Development Letter have?
To see how many people subscribe to The Drug Development Letter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Drug Development Letter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Drug Development Letter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Drug Development Letter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Drug Development Letter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to The Drug Development Letter?
Scroll up to where it says Related Newsletters to see other publications like The Drug Development Letter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Drug Development Letter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.